Join the Oncology Voice Network. Join for Free
How to create HIGH performing MSLs, teams and MSL leaders
field medical development evolving role of MSLs executive coaching soft skills for MSLs high-performing MSL teams

How to create HIGH performing MSLs, teams and MSL leaders


Share This Article


Summary

In this episode, Mike Penkethman delves into field medical development and the evolving role of MSLs. He emphasizes the importance of executive coaching, soft skills, and adapting to pandemic-driven changes. Mike provides insights into the attributes of high-performing MSLs, especially in virtual settings, and discusses the evaluation of MSL teams. He highlights strategies for team development, goal setting, and the significance of networking and centers of influence. The conversation also covers practical advice on verbalizing and documenting goals, honing soft skills, and crafting a compelling CV for aspiring MSLs. The episode concludes with reflective closing remarks and gratitude.

Check out my latest podcast with Mike Penkethman, Career Coach and President of the Pilotage Group. We discuss how to create high-performing MSLs, teams, and MSL leaders.

We discuss:

 What are the key attributes of high performing MSL
 What MSL interactions will look like in the future
 What do MSL Leaders look for in MSLs
 What is the most successful approach to KOL interactions
 What value and resources can (and should) MSLs bring to their KOLs

Click for Source
field medical development, evolving role of MSLs, executive coaching, soft skills for MSLs, high-performing MSL teams

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Article
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
OVN Avatar B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Explore OVN